519 related articles for article (PubMed ID: 24184714)
1. Prophylactic systemic P2X7 receptor blockade prevents experimental colitis.
Marques CC; Castelo-Branco MT; Pacheco RG; Buongusto F; do Rosário A; Schanaider A; Coutinho-Silva R; de Souza HS
Biochim Biophys Acta; 2014 Jan; 1842(1):65-78. PubMed ID: 24184714
[TBL] [Abstract][Full Text] [Related]
2. Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats.
Pereira JMS; Barreira AL; Gomes CR; Ornellas FM; Ornellas DS; Miranda LC; Cardoso LR; Coutinho-Silva R; Schanaider A; Morales MM; Leite M; Takiya CM
BMC Nephrol; 2020 May; 21(1):206. PubMed ID: 32471386
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proprotein convertase subtilisin/kexin type 9 attenuates 2,4,6-trinitrobenzenesulfonic acid-induced colitis via repressing toll-like receptor 4/nuclear factor-kappa B.
Lei L; Li X; Yuan YJ; Chen ZL; He JH; Wu JH; Cai XS
Kaohsiung J Med Sci; 2020 Sep; 36(9):705-711. PubMed ID: 32396274
[TBL] [Abstract][Full Text] [Related]
4. Effects of a P2X7 receptor antagonist on myenteric neurons in the distal colon of an experimental rat model of ulcerative colitis.
Evangelinellis MM; Souza RF; Mendes CE; Castelucci P
Histochem Cell Biol; 2022 Jan; 157(1):65-81. PubMed ID: 34626216
[TBL] [Abstract][Full Text] [Related]
5. Timosaponin AIII and its metabolite sarsasapogenin ameliorate colitis in mice by inhibiting NF-κB and MAPK activation and restoring Th17/Treg cell balance.
Lim SM; Jeong JJ; Kang GD; Kim KA; Choi HS; Kim DH
Int Immunopharmacol; 2015 Apr; 25(2):493-503. PubMed ID: 25698557
[TBL] [Abstract][Full Text] [Related]
6. BBG enhances OLT1177-induced NLRP3 inflammasome inactivation by targeting P2X7R/NLRP3 and MyD88/NF-κB signaling in DSS-induced colitis in rats.
Saber S; Youssef ME; Sharaf H; Amin NA; El-Shedody R; Aboutouk FH; El-Galeel YA; El-Hefnawy A; Shabaka D; Khalifa A; Saleh RA; Osama D; El-Zoghby G; Gobba NA
Life Sci; 2021 Apr; 270():119123. PubMed ID: 33548287
[TBL] [Abstract][Full Text] [Related]
7. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
[TBL] [Abstract][Full Text] [Related]
8. The Beneficial Effects of P2X7 Antagonism in Rats with Bile Duct Ligation-induced Cirrhosis.
Tung HC; Lee FY; Wang SS; Tsai MH; Lee JY; Huo TI; Huang HC; Chuang CL; Lin HC; Lee SD
PLoS One; 2015; 10(5):e0124654. PubMed ID: 25933224
[TBL] [Abstract][Full Text] [Related]
9. P2X7 receptor blockade prevents preterm birth and perinatal brain injury in a mouse model of intrauterine inflammation.
Tsimis ME; Lei J; Rosenzweig JM; Arif H; Shabi Y; Alshehri W; Talbot CC; Baig-Ward KM; Segars J; Graham EM; Burd I
Biol Reprod; 2017 Aug; 97(2):230-239. PubMed ID: 29044426
[TBL] [Abstract][Full Text] [Related]
10. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
Zeng Z; Zhan L; Liao H; Chen L; Lv X
Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
[TBL] [Abstract][Full Text] [Related]
12. P2X7 receptor antagonism inhibits p38 mitogen-activated protein kinase activation and ameliorates neuronal apoptosis after subarachnoid hemorrhage in rats.
Chen S; Ma Q; Krafft PR; Chen Y; Tang J; Zhang J; Zhang JH
Crit Care Med; 2013 Dec; 41(12):e466-74. PubMed ID: 23963136
[TBL] [Abstract][Full Text] [Related]
13. Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption.
Wu X; Ren J; Chen G; Wu L; Song X; Li G; Deng Y; Wang G; Gu G; Li J
Sci Rep; 2017 Jun; 7(1):4364. PubMed ID: 28663567
[TBL] [Abstract][Full Text] [Related]
14. Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.
Lim SM; Kang GD; Jeong JJ; Choi HS; Kim DH
Phytomedicine; 2016 Feb; 23(2):131-40. PubMed ID: 26926174
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a hydroxynaphthoquinone fraction from Arnebia euchroma in rats with experimental colitis.
Fan HY; Zhang ZL; Liu K; Yang MY; Lv WH; Che X; Xu H; Song WW
World J Gastroenterol; 2013 Dec; 19(48):9318-27. PubMed ID: 24409058
[TBL] [Abstract][Full Text] [Related]
16. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
17. Blockade of ATP P2X7 receptor enhances ischiatic nerve regeneration in mice following a crush injury.
Ribeiro T; Oliveira JT; Almeida FM; Tomaz MA; Melo PA; Marques SA; de Andrade GM; Martinez AMB
Brain Res; 2017 Aug; 1669():69-78. PubMed ID: 28554806
[TBL] [Abstract][Full Text] [Related]
18. The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon-γ in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Belfiore L; Ly D; Adhikary SR; Fuller SJ; Varikatt W; Sanderson-Smith ML; Sluyter V; Alexander SI; Sluyter R; Watson D
Clin Exp Immunol; 2017 Oct; 190(1):79-95. PubMed ID: 28665482
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
20. Lymphtoxin beta receptor-Ig ameliorates TNBS-induced colitis via blocking LIGHT/HVEM signaling.
An MM; Fan KX; Zhang JD; Li HJ; Song SC; Liu BG; Gao PH; Zhou Q; Jiang YY
Pharmacol Res; 2005 Sep; 52(3):234-44. PubMed ID: 15925518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
